.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
AstraZeneca
Accenture
Chinese Patent Office
Cipla
Covington
Farmers Insurance
Healthtrust
Fish and Richardson
Dow

Generated: June 25, 2017

DrugPatentWatch Database Preview

VIOCIN SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Viocin Sulfate, and when can generic versions of Viocin Sulfate launch?

Viocin Sulfate is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in VIOCIN SULFATE is viomycin sulfate. There is one drug master file entry for this compound. Additional details are available on the viomycin sulfate profile page.

Summary for Tradename: VIOCIN SULFATE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list5
Clinical Trials: see list634
Patent Applications: see list29
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VIOCIN SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
VIOCIN SULFATE
viomycin sulfate
INJECTABLE;INJECTION061086-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
VIOCIN SULFATE
viomycin sulfate
INJECTABLE;INJECTION061086-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
AstraZeneca
Cerilliant
Fish and Richardson
QuintilesIMS
McKinsey
Harvard Business School
Healthtrust
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot